Joincare Pharmaceutical Group Industry Co.,Ltd. (SWX:JCARE)
Switzerland flag Switzerland · Delayed Price · Currency is CHF · Price in USD
8.00
0.00 (0.00%)
At close: Jan 29, 2026

SWX:JCARE Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
15,07115,49216,52217,01315,74713,446
Other Revenue
127.91127.91124.63130.02157.0675.73
15,19815,61916,64617,14315,90413,522
Revenue Growth (YoY)
-4.38%-6.17%-2.90%7.79%17.62%12.87%
Cost of Revenue
5,9606,0996,6086,3805,7784,944
Gross Profit
9,2399,52110,03910,76310,1268,577
Selling, General & Admin
4,8744,8365,3685,9445,9664,898
Research & Development
1,3301,4351,6621,7421,3971,072
Other Operating Expenses
164.73155.49177.21196.72180.8161.03
Operating Expenses
6,3826,4317,2247,8857,5536,136
Operating Income
2,8573,0902,8152,8772,5722,442
Interest Expense
-95.11-123.26-146.73-139.02-90.28-35.69
Interest & Investment Income
613.21481.67611.73451.45263.85385.8
Currency Exchange Gain (Loss)
22.8722.8727.25104.46-2.74-62.35
Other Non Operating Income (Expenses)
-12.63-17.81-7.69-9.62-4.89-7.72
EBT Excluding Unusual Items
3,3853,4533,3003,2852,7382,722
Gain (Loss) on Sale of Investments
-8.43-17.5-25.42-76.26-23.5110.22
Gain (Loss) on Sale of Assets
45.3245.26-0.17-0.7124.04-7.19
Asset Writedown
62.72-30.09-3.27-31.51-8.25-4.18
Other Unusual Items
123.81123.81194.75280.06221.66229.61
Pretax Income
3,6083,5753,4663,4562,9522,950
Income Tax Expense
614.7592.14614.54561.8339.48371.69
Earnings From Continuing Operations
2,9942,9832,8512,8942,6132,578
Minority Interest in Earnings
-1,627-1,596-1,408-1,392-1,284-1,458
Net Income
1,3661,3871,4431,5031,3281,120
Net Income to Common
1,3661,3871,4431,5031,3281,120
Net Income Growth
-7.10%-3.90%-3.99%13.12%18.57%25.28%
Shares Outstanding (Basic)
1,8251,8741,8981,8941,9351,948
Shares Outstanding (Diluted)
1,8251,8741,8981,8971,9371,956
Shares Change (YoY)
-2.99%-1.30%0.07%-2.07%-0.97%0.76%
EPS (Basic)
0.750.740.760.790.690.58
EPS (Diluted)
0.750.740.760.790.690.57
EPS Growth
-4.24%-2.63%-4.06%15.52%19.73%24.33%
Free Cash Flow
3,1382,6572,7992,8301,0422,195
Free Cash Flow Per Share
1.721.421.471.490.541.12
Dividend Per Share
0.2000.2000.1800.1800.1500.150
Dividend Growth
11.11%11.11%-20.00%--6.25%
Gross Margin
60.79%60.96%60.31%62.78%63.67%63.43%
Operating Margin
18.80%19.78%16.91%16.78%16.18%18.06%
Profit Margin
8.99%8.88%8.67%8.77%8.35%8.29%
Free Cash Flow Margin
20.65%17.01%16.81%16.51%6.55%16.23%
EBITDA
3,4473,8663,8373,6833,1672,989
EBITDA Margin
22.68%24.75%23.05%21.48%19.91%22.10%
D&A For EBITDA
590.78775.671,022805.34594.45546.91
EBIT
2,8573,0902,8152,8772,5722,442
EBIT Margin
18.80%19.78%16.91%16.78%16.18%18.06%
Effective Tax Rate
17.04%16.56%17.73%16.25%11.50%12.60%
Revenue as Reported
15,19815,61916,64617,14315,90413,522
Source: S&P Global Market Intelligence. Standard template. Financial Sources.